127 related articles for article (PubMed ID: 38306734)
21. Accuracy of SARC-F and SARC-CalF for sarcopenia screening in older women from southern Brazil.
Mazocco L; Chagas P; Barbosa-Silva TG; Gonzalez MC; Schwanke CHA
Nutrition; 2020; 79-80():110955. PubMed ID: 32919183
[TBL] [Abstract][Full Text] [Related]
22. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia.
Beaudart C; Edwards M; Moss C; Reginster JY; Moon R; Parsons C; Demoulin C; Rizzoli R; Biver E; Dennison E; Bruyere O; Cooper C
Age Ageing; 2017 Mar; 46(2):271-276. PubMed ID: 27789428
[TBL] [Abstract][Full Text] [Related]
23. Psychometric Properties of the Spanish Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia.
Fábrega-Cuadros R; Martínez-Amat A; Cruz-Díaz D; Aibar-Almazán A; Hita-Contreras F
Calcif Tissue Int; 2020 Mar; 106(3):274-282. PubMed ID: 31781790
[TBL] [Abstract][Full Text] [Related]
24. Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia.
Demonceau C; Voz B; Bruyère O; Reginster JY; Beaudart C
Aging Clin Exp Res; 2024 Apr; 36(1):101. PubMed ID: 38710959
[TBL] [Abstract][Full Text] [Related]
25. Reliability and Concurrent Validity of the SARC-F and Its Modified Versions: A Systematic Review and Meta-Analysis.
Voelker SN; Michalopoulos N; Maier AB; Reijnierse EM
J Am Med Dir Assoc; 2021 Sep; 22(9):1864-1876.e16. PubMed ID: 34144049
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions.
Beaudart C; Locquet M; Reginster JY; Delandsheere L; Petermans J; Bruyère O
Aging Clin Exp Res; 2018 Apr; 30(4):307-313. PubMed ID: 29197020
[TBL] [Abstract][Full Text] [Related]
27. SARC-F and other screening tests for sarcopenia.
Bahat G; Erdoğan T; İlhan B
Curr Opin Clin Nutr Metab Care; 2022 Jan; 25(1):37-42. PubMed ID: 34861669
[TBL] [Abstract][Full Text] [Related]
28. Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia.
Gasparik AI; Mihai G; Beaudart C; Bruyere O; Pop RM; Reginster JY; Pascanu IM
Arch Osteoporos; 2017 Nov; 12(1):103. PubMed ID: 29139012
[TBL] [Abstract][Full Text] [Related]
29. SARC-F and SARC-CalF are associated with sarcopenia traits in hemodialysis patients.
P Duarte M; Ribeiro HS; Almeida LS; Baião VM; Inda-Filho A; Avesani CM; Ferreira AP; Lima RM
Nutr Clin Pract; 2022 Dec; 37(6):1356-1365. PubMed ID: 34994475
[TBL] [Abstract][Full Text] [Related]
30. Utility of SARC-F in daycare facilities for older people.
Kera T; Saida K; Higuchi D; Shinohara T; Onozawa H; Kawai H; Obuchi S
Geriatr Gerontol Int; 2022 Oct; 22(10):889-893. PubMed ID: 36059047
[TBL] [Abstract][Full Text] [Related]
31. Clinical validation of SARC-F by proxy as a practical tool to evaluate sarcopenia in dependent older adults.
Ozkok S; Oren MM; Aydin CO; Ozalp H; Kilic C; Koc Y; Dogan H; Eryigit OY; Karan MA; Bahat G
J Geriatr Oncol; 2023 Nov; 14(8):101630. PubMed ID: 37741772
[TBL] [Abstract][Full Text] [Related]
32. Screening Tools for Sarcopenia.
Nishikawa H; Asai A; Fukunishi S; Takeuchi T; Goto M; Ogura T; Nakamura S; Kakimoto K; Miyazaki T; Nishiguchi S; Higuchi K
In Vivo; 2021; 35(6):3001-3009. PubMed ID: 34697131
[TBL] [Abstract][Full Text] [Related]
33. SARC-CalF-assessed risk of sarcopenia and associated factors in cancer patients.
Souza VF; Ribeiro TSC; Marques RA; Petarli GB; Pereira TSS; Rocha JLM; Guandalini VR
Nutr Hosp; 2020 Dec; 37(6):1173-1178. PubMed ID: 32960621
[TBL] [Abstract][Full Text] [Related]
34. A leaky gut contributes to reduced sarcopenia-related quality of life (SarQoL) in geriatric older adults.
Qaisar R; Iqbal MS; Karim A; Muhammad T; Ahmad F
Qual Life Res; 2024 Feb; 33(2):551-559. PubMed ID: 37930557
[TBL] [Abstract][Full Text] [Related]
35. Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.
Beaudart C; Reginster JY; Amuthavalli Thiyagarajan J; Bautmans I; Bauer J; Burlet N; Cesari M; Cherubini A; Cooper C; Cruz-Jentoft AJ; Dawson-Hughes B; Fielding RA; Harvey NC; Landi F; Laslop A; Maggi S; Montero-Errasquin B; Concepción PYM; Rolland Y; Rizzoli R; Visser M; Bruyère O
Aging Clin Exp Res; 2023 Aug; 35(8):1581-1593. PubMed ID: 37219755
[TBL] [Abstract][Full Text] [Related]
36. Prognostic utility of self-reported sarcopenia (SARC-F) in the Multiethnic Cohort.
Wu AH; Setiawan VW; Lim U; Tseng CC; White KK; Shepherd J; Lenz HJ; Cheng I; Stram DO; Haiman C; Wilkens LR; Le Marchand L
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):987-1002. PubMed ID: 35098697
[TBL] [Abstract][Full Text] [Related]
37. Design and methodology of the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis: the SARC-HD study.
Duarte MP; Pereira MS; Baião VM; Vieira FA; Silva MZC; Krug RR; Inda-Filho AJ; Ferreira AP; Lima RM; Avesani CM; Nóbrega OT; Reboredo MM; Ribeiro HS;
BMC Nephrol; 2023 Aug; 24(1):239. PubMed ID: 37582699
[TBL] [Abstract][Full Text] [Related]
38. Practical screening tools for sarcopenia in patients with systemic sclerosis.
Hax V; do Espírito Santo RC; Dos Santos LP; Farinon M; de Oliveira MS; Três GL; Gasparin AA; de Andrade NPB; Bredemeier M; Xavier RM; Chakr RMDS
PLoS One; 2021; 16(1):e0245683. PubMed ID: 33481872
[TBL] [Abstract][Full Text] [Related]
39. Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairments.
Maurus J; Terzer T; Benner A; Goisser S; Eidam A; Roth A; Janssen M; Jaramillo S; Lorenz HM; Micol W; Hauer K; Müller-Tidow C; Bauer JM; Jordan K; Neuendorff NR
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):264-275. PubMed ID: 34898035
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
